Core Viewpoint - Jiangsu Hualan Pharmaceutical New Materials Co., Ltd. has announced a share repurchase plan using raised funds, self-owned funds, and self-raised funds through centralized bidding, with a total repurchase amount between RMB 100 million and RMB 200 million [2][3]. Summary by Sections Share Repurchase Plan - The company plans to use a total of no less than RMB 100 million and no more than RMB 200 million for the share repurchase, with at least RMB 30 million and no more than RMB 60 million coming from raised funds [2]. - The repurchased shares will be used for cancellation to reduce registered capital and for employee stock ownership plans or equity incentives [2]. Price Adjustment - Following the implementation of the 2024 annual equity distribution, the maximum repurchase price has been adjusted from RMB 45.50 per share to RMB 34.84 per share, effective from July 14, 2025 [3]. Repurchase Details - The repurchase plan includes a target quantity of shares to be repurchased ranging from 2,009,185 to 4,018,369 shares, which represents approximately 1.75% to 3.50% of the company's total shares [4]. - As of July 31, 2025, the company has not yet implemented the share repurchase [4].
华兰股份: 关于使用超募资金、自有资金及自筹资金以集中竞价交易方式回购公司股份的进展公告